Multiscan

What Multiscan does

Multiscan s.r.o. is a Czech Republic-based private healthcare provider operating as a comprehensive oncology and radiology center, designated as the Komplexní onkologické centrum (KOC) Pardubického kraje — the Comprehensive Oncology Center of the Pardubice Region. The company is a subsidiary of AKESO holding a.s., which is owned by Ing. Sotirios Zavalianis, and operates seven locations across Pardubice, Chrudim, Svitavy, Ústí nad Orlicí, Hořovice, and Prague. Its service portfolio spans clinical oncology, radiation oncology (including linear accelerators and brachytherapy), radiodiagnostics, palliative care, preventive medicine, genetic counseling, physiotherapy, and an in-house pharmacy division called Multiscan Pharma that supports clinical trial participation.

The company's revenue model is anchored in the Czech public healthcare reimbursement system, serving insured patients through regional referrals for complex oncology care, supplemented by self-pay preventive and screening services. Multiscan holds ISO 9001 certification from TÜV SÜD and was awarded the Czech Best Managed Companies 2026 Platinum Award by Deloitte, reflecting recognized quality management standards. The company has secured EU structural funding — including EU Next Generation support in 2025 and a prior EU OP Zaměstnanost grant in 2018 — and has committed to an 84 million CZK equipment modernization program to upgrade radiotherapy and diagnostic imaging technology.

Operationally, Multiscan runs a multi-modality, multi-site clinical platform with named clinical leadership in radiation oncology, clinical oncology, medical physics, and radiodiagnostics. The integration of pharmacy, palliative care, and genetic counseling under a single entity creates a vertically oriented oncology care pathway. Its strategic positioning as a regional KOC center creates regulatory protection from new entrants while its seven-site distribution creates patient access advantages within its catchment area.

Name

Multiscan

Legal name

Multiscan s.r.o.

Website

https://multiscan.cz

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

51–100 employees

Short description

Multiscan is a Czech Republic-based comprehensive oncology and radiology center operating seven locations as the designated KOC of the Pardubice Region, delivering clinical oncology, radiation therapy, diagnostics, and pharmacy services to insured and self-pay patients.

Ownership category

akta.pro rank

Product category

Oncology and Radiology Healthcare Services

NAICS

Offices of Physicians (62111), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC), Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Oncology treatment services
• Radiation oncology therapy
• Cancer diagnostic imaging
• Radiology diagnostic services
• Palliative cancer care

Headquarters

HQ city

Pardubice

HQ country

Czechia

HQ region

Europe

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Oncology Services: Provides outpatient clinical oncology consultations, chemotherapy administration, and ongoing cancer care management. Services are primarily covered through public health insurance in Czech Republic.
2. Radiation Oncology: Radiotherapy treatments including linear accelerator treatments and brachytherapy, funded through health insurance and EU-supported equipment modernization.
3. Radiodiagnostics: Diagnostic imaging services including MRI, CT, X-ray, and ultrasound, available both through public insurance and self-payer arrangements.
4. Self-Payer Services: Private healthcare services for patients without public insurance coverage or seeking faster access to diagnostic and treatment services.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Multiscan is a Comprehensive Oncology Center providing integrated cancer care through three main service lines: clinical oncology (chemotherapy administration and medical oncology consultations), radiation oncology (linear accelerator external beam radiotherapy, brachytherapy, and CT simulation), and radiodiagnostics (MRI, CT, X-ray, ultrasound, and lung screening). The center supplements these core services with palliative care, hereditary cancer syndrome counseling, preventive screening, oncology physiotherapy, and clinical trials support through its Multiscan Pharma unit, operating across the Pardubice Region and Hořovice.

Product overview

Multiscan is a comprehensive oncology and radiology center operating as part of the AKESO holding group. The organization provides an integrated healthcare portfolio consisting of Clinical Oncology Services (chemotherapy and medical oncology across multiple regional locations), Radiation Oncology (external beam radiotherapy, brachytherapy, linear accelerator treatments), and Radiodiagnostics (MRI, CT, X-ray, ultrasound, lung screening). Specialized services include palliative care, preventive medicine, hereditary cancer syndrome counseling, and oncology physiotherapy. The subsidiary Multiscan Pharma supports clinical trials and pharmaceutical services. Multiscan serves as part of the Comprehensive Oncology Center of the Pardubice Region (KOC PK).

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Oncology Services
• Radiation Oncology
• Radiodiagnostics
• Palliative Care
• Preventive Outpatient Clinic
• Hereditary Cancer Syndromes
• Oncology Physiotherapy
• Multiscan Pharma
• Lung Screening
• Linear Accelerator Treatment
• Brachytherapy

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered minor and core.

• European Union / OP ZaměstnanostminorOthers · 26 March 2018EU-funded employee education project (CZ.03.1.52/0.0/0.0/16_043/0004691) with maximum support of 729,132 CZK for staff training and professional development.
• AKESO HoldingcoreOthersMultiscan is a subsidiary of AKESO Holding, a healthcare group operating multiple hospitals, rehabilitation facilities, and outpatient clinics across Czech Republic including Nemocnice Hořovice, Rehabilitační nemocnice Beroun, and various AKESO POLIKLINIKA locations. The holding provides corporate governance, shared services, and strategic direction.
• Komplexní onkologické centrum Pardubického kraje (KOC PK)coreStrategic or Co-development PartnerMultiscan is an integral part of the Comprehensive Oncology Center of the Pardubice Region (KOC PK), a formal regional healthcare designation for specialized oncology services requiring multidisciplinary coordination and adherence to treatment standards.
• European Union / Nástroj pro oživení a odolnostcoreOthersEU-funded project (CZ.31.8.0/0.0/0.0/23_072/0008223) supporting equipment modernization for advanced diagnostics and radiotherapy treatment through National Recovery Plan of Czech Republic.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• General University Hospital Prague (VFN) — Onkologická klinika: Prague-based academic comprehensive cancer center providing full-scope medical, radiation, and surgical oncology. Comparable as a competing Czech KOC with multidisciplinary cancer care, clinical research, and complex case referral infrastructure.
• FN Brno — Masaryk University Hospital Oncology Center: Large university hospital providing comprehensive cancer care including chemotherapy, radiotherapy, and radiodiagnostics in Moravia. Comparable as another full-service Czech academic KOC competitor.
• University Hospital Ostrava — Comprehensive Oncology Center: Designated KOC for the Moravian-Silesian region offering chemotherapy, radiotherapy, and oncological diagnostics. Comparable as one of the regional KOCs in the Czech network competing with Multiscan for tertiary oncology referrals.
• University Hospital Olomouc — KOC PK region competitor: Czech university hospital functioning as a Comprehensive Oncology Center with radiation oncology and chemotherapy services. Comparable as a regional Czech KOC competing for insured oncology patients and physician talent.
• Proton Therapy Center Czech: Prague-based specialized radiotherapy center offering advanced particle therapy and conventional radiotherapy. Comparable as a Czech specialty cancer treatment provider competing for complex radiotherapy cases that Multiscan's linear accelerators also aim to capture.
• Masaryk Memorial Cancer Institute (MOÚ Brno): The largest Czech specialized oncology hospital and KOC, located in Brno. Directly comparable to Multiscan as a Comprehensive Oncology Center providing radiation oncology, medical oncology, and radiodiagnostics across multiple locations in the Czech Republic.
• University Hospital Hradec Králové — KOC: Czech university hospital with comprehensive oncology, radiotherapy, and imaging services serving the eastern Bohemian region. Comparable as a neighboring KOC competing for patient referrals in geographies adjacent to Multiscan's Pardubice catchment.

Regional players

• MEDESA — Czech radiotherapy provider chain: Czech private radiotherapy and oncology services operator with multiple regional sites. Comparable as a competing private radiotherapy operator in the Czech market targeting similar insured oncology patient volumes.

Broad incumbents

• Agel — Czech private healthcare network: Largest Czech private healthcare operator running hospitals, clinics, and specialty centers including oncology services. Comparable as a multi-site private healthcare competitor with broader geographic reach than Multiscan.

Others

• AKESO Holding hospitals (Nemocnice Hořovice, Beroun): Sister facilities under the same parent holding as Multiscan. Not direct competitors but adjacent providers within the AKESO network that share governance, capital allocation, and patient referral pathways with Multiscan.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCfkF3TdAFHKKl5wDMJr139Q/featured
• Facebookfacebook.com/MultiscanCZ
• LinkedInlinkedin.com/company/multiscanpardubice

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Multiscan